SORTERA BIO LIMITED
15052487Research and experimental development on biotechnology
SORTERA BIO LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Sovereign House Vision Park Cambridge CB24 9BZ United Kingdom
Full company profile for SORTERA BIO LIMITED (15052487), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 7 Aug 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2024–2024)
Cash in Bank
£1.94M
Net Assets
£2.68M
Total Liabilities
£701.66k
Turnover
N/A
Employees
4
Debt Ratio
21%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | |
|---|---|
| P&L | |
| Revenue | |
| Gross Profit | |
| Operating Profit | |
| Net Profit | |
| EBITDA | |
| Assets | |
| Cash | |
| Total Assets | |
| Liabilities | |
| Total Liabilities | |
| Key Metrics | |
| Employees | |
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Llewellyn, David Colin Conway, Dr | Director | British | United Kingdom | 3 Nov 2025 | Active |
| Michael John Skynner | Director | British | United Kingdom | 1 Aug 2024 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Cicgp Llp
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Kaspar Philipp Holliger
Ceased 15 Sept 2023
Benjamin Thomas Porebski
Ceased 30 May 2025
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 1 Jun 2026 | Capital | Allotment of shares (GBP 1,167.7856) on 3 Apr 2026 | |
| 17 Nov 2025 | Officers | Appointment of Dr David Colin Conway Llewellyn as director on 3 Nov 2025 | |
| 6 Oct 2025 | Capital | Allotment of shares (GBP 1,141.349) on 4 Sept 2025 | |
| 19 Aug 2025 | Officers | Change to director Benjamin Thomas Porebski on 15 Nov 2024 | |
| 19 Aug 2025 | Persons With Significant Control | Change to Benjamin Thomas Porebski as a person with significant control on 15 Nov 2024 |
Allotment of shares (GBP 1,167.7856) on 3 Apr 2026
Appointment of Dr David Colin Conway Llewellyn as director on 3 Nov 2025
Allotment of shares (GBP 1,141.349) on 4 Sept 2025
Change to director Benjamin Thomas Porebski on 15 Nov 2024
Change to Benjamin Thomas Porebski as a person with significant control on 15 Nov 2024
Recent Activity
Latest Activity
Allotment of shares (GBP 1,167.7856) on 3 Apr 2026
1 weeks ago on 1 Jun 2026
Appointment of Dr David Colin Conway Llewellyn as director on 3 Nov 2025
6 months ago on 17 Nov 2025
Allotment of shares (GBP 1,141.349) on 4 Sept 2025
8 months ago on 6 Oct 2025
Change to director Benjamin Thomas Porebski on 15 Nov 2024
9 months ago on 19 Aug 2025
Change to Benjamin Thomas Porebski as a person with significant control on 15 Nov 2024
9 months ago on 19 Aug 2025